This data underlines how obesity affects the IGF-1 values, but once steatosis or, even more so, steatohepatitis is established, IGF1 levels are influenced by the presence of steatosis and/or fibrosis as well as by the glycemic profile, regardless of the BMI value. This evidence concerns the gene IGF1 and obesity disorder.